Loading…

Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells

Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodec...

Full description

Saved in:
Bibliographic Details
Published in:International journal of peptide research and therapeutics 2022-03, Vol.28 (2), Article 67
Main Authors: Sancar, Serap, Bolkent, Sehnaz
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413
cites cdi_FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413
container_end_page
container_issue 2
container_start_page
container_title International journal of peptide research and therapeutics
container_volume 28
creator Sancar, Serap
Bolkent, Sehnaz
description Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodecapeptide (CDP), which is an AMP on MCF-7 and MDA-MB 231 cells from breast cancer cell lines for the first time. Anticancer activity and mechanism of action of CDP were investigated via cancer cell viability assay, cell cytotoxic assay, acridine orange/ethidium bromide dual fluorescence dying assay and scanning electron microscope technique, solid phase heparan sulfate and chondroitin sulfate binding assay, and peptide binding assay. CDP decreases cell viability and induces the death of breast cancer cells by impairing the membrane integrity and causes necrotic cell death by forming pores in the membranes. CDP binds to the negatively charged glycosaminoglycans and shows more affinity against breast cancer cells than fibroblast cells. As a result, the anticancer activity of CDP presented for the first time against breast cancer cells and it has a therapeutic value due to its selective toxicity. Graphical Abstract
doi_str_mv 10.1007/s10989-022-10369-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2627006932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2627006932</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413</originalsourceid><addsrcrecordid>eNp9kL1OwzAUhS0EEqXwAkyWmAPXdh3bI6T8VCqCocyW7ThtqjQpdjKw8Q68IU9C2vCzMd0zfOdc6UPonMAlARBXkYCSKgFKEwIsVQk9QCPCBUuYgsnhTyYTdYxOYlwDcCoIjFCRvbmqdHja5N6Zrd-2Ze7xrM475yPOfFXhqTftCi9WoemWK_zoNzaY2n--fzz_0q0PxrVlU0dc1vgmeBNbnJna-bDfiKfoqDBV9Gffd4xe7m4X2UMyf7qfZdfzxDGi2sRYqSyzCoBKYERaYgRnPBXGSGK9YNwUQhKeklzmhlguQXGeMs5MYfMJYWN0MexuQ_Pa-djqddOFun-paUoFQKoY7Sk6UC40MQZf6G0oNya8aQJ651MPPnXvU-996l2JDaXYw_XSh7_pf1pfswR4jQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2627006932</pqid></control><display><type>article</type><title>Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells</title><source>Springer Link</source><creator>Sancar, Serap ; Bolkent, Sehnaz</creator><creatorcontrib>Sancar, Serap ; Bolkent, Sehnaz</creatorcontrib><description>Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodecapeptide (CDP), which is an AMP on MCF-7 and MDA-MB 231 cells from breast cancer cell lines for the first time. Anticancer activity and mechanism of action of CDP were investigated via cancer cell viability assay, cell cytotoxic assay, acridine orange/ethidium bromide dual fluorescence dying assay and scanning electron microscope technique, solid phase heparan sulfate and chondroitin sulfate binding assay, and peptide binding assay. CDP decreases cell viability and induces the death of breast cancer cells by impairing the membrane integrity and causes necrotic cell death by forming pores in the membranes. CDP binds to the negatively charged glycosaminoglycans and shows more affinity against breast cancer cells than fibroblast cells. As a result, the anticancer activity of CDP presented for the first time against breast cancer cells and it has a therapeutic value due to its selective toxicity. Graphical Abstract</description><identifier>ISSN: 1573-3149</identifier><identifier>EISSN: 1573-3904</identifier><identifier>DOI: 10.1007/s10989-022-10369-2</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Acridine orange ; Animal Anatomy ; Antimicrobial agents ; Antimicrobial peptides ; Antitumor activity ; Apoptosis ; Biochemistry ; Biomedical and Life Sciences ; Breast cancer ; Cell death ; Cell membranes ; Cell viability ; Chondroitin sulfate ; Cytotoxicity ; Ethidium bromide ; Glycosaminoglycans ; Heparan sulfate ; Histology ; Life Sciences ; Molecular Medicine ; Morphology ; Peptides ; Pharmaceutical Sciences/Technology ; Pharmacology/Toxicology ; Polymer Sciences ; Scanning electron microscopy ; Tumor cell lines ; Tumors</subject><ispartof>International journal of peptide research and therapeutics, 2022-03, Vol.28 (2), Article 67</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2022</rights><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413</citedby><cites>FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413</cites><orcidid>0000-0002-7093-4744</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sancar, Serap</creatorcontrib><creatorcontrib>Bolkent, Sehnaz</creatorcontrib><title>Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells</title><title>International journal of peptide research and therapeutics</title><addtitle>Int J Pept Res Ther</addtitle><description>Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodecapeptide (CDP), which is an AMP on MCF-7 and MDA-MB 231 cells from breast cancer cell lines for the first time. Anticancer activity and mechanism of action of CDP were investigated via cancer cell viability assay, cell cytotoxic assay, acridine orange/ethidium bromide dual fluorescence dying assay and scanning electron microscope technique, solid phase heparan sulfate and chondroitin sulfate binding assay, and peptide binding assay. CDP decreases cell viability and induces the death of breast cancer cells by impairing the membrane integrity and causes necrotic cell death by forming pores in the membranes. CDP binds to the negatively charged glycosaminoglycans and shows more affinity against breast cancer cells than fibroblast cells. As a result, the anticancer activity of CDP presented for the first time against breast cancer cells and it has a therapeutic value due to its selective toxicity. Graphical Abstract</description><subject>Acridine orange</subject><subject>Animal Anatomy</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial peptides</subject><subject>Antitumor activity</subject><subject>Apoptosis</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Breast cancer</subject><subject>Cell death</subject><subject>Cell membranes</subject><subject>Cell viability</subject><subject>Chondroitin sulfate</subject><subject>Cytotoxicity</subject><subject>Ethidium bromide</subject><subject>Glycosaminoglycans</subject><subject>Heparan sulfate</subject><subject>Histology</subject><subject>Life Sciences</subject><subject>Molecular Medicine</subject><subject>Morphology</subject><subject>Peptides</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology/Toxicology</subject><subject>Polymer Sciences</subject><subject>Scanning electron microscopy</subject><subject>Tumor cell lines</subject><subject>Tumors</subject><issn>1573-3149</issn><issn>1573-3904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kL1OwzAUhS0EEqXwAkyWmAPXdh3bI6T8VCqCocyW7ThtqjQpdjKw8Q68IU9C2vCzMd0zfOdc6UPonMAlARBXkYCSKgFKEwIsVQk9QCPCBUuYgsnhTyYTdYxOYlwDcCoIjFCRvbmqdHja5N6Zrd-2Ze7xrM475yPOfFXhqTftCi9WoemWK_zoNzaY2n--fzz_0q0PxrVlU0dc1vgmeBNbnJna-bDfiKfoqDBV9Gffd4xe7m4X2UMyf7qfZdfzxDGi2sRYqSyzCoBKYERaYgRnPBXGSGK9YNwUQhKeklzmhlguQXGeMs5MYfMJYWN0MexuQ_Pa-djqddOFun-paUoFQKoY7Sk6UC40MQZf6G0oNya8aQJ651MPPnXvU-996l2JDaXYw_XSh7_pf1pfswR4jQ</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Sancar, Serap</creator><creator>Bolkent, Sehnaz</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0002-7093-4744</orcidid></search><sort><creationdate>20220301</creationdate><title>Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells</title><author>Sancar, Serap ; Bolkent, Sehnaz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acridine orange</topic><topic>Animal Anatomy</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial peptides</topic><topic>Antitumor activity</topic><topic>Apoptosis</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Breast cancer</topic><topic>Cell death</topic><topic>Cell membranes</topic><topic>Cell viability</topic><topic>Chondroitin sulfate</topic><topic>Cytotoxicity</topic><topic>Ethidium bromide</topic><topic>Glycosaminoglycans</topic><topic>Heparan sulfate</topic><topic>Histology</topic><topic>Life Sciences</topic><topic>Molecular Medicine</topic><topic>Morphology</topic><topic>Peptides</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology/Toxicology</topic><topic>Polymer Sciences</topic><topic>Scanning electron microscopy</topic><topic>Tumor cell lines</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sancar, Serap</creatorcontrib><creatorcontrib>Bolkent, Sehnaz</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of peptide research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sancar, Serap</au><au>Bolkent, Sehnaz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells</atitle><jtitle>International journal of peptide research and therapeutics</jtitle><stitle>Int J Pept Res Ther</stitle><date>2022-03-01</date><risdate>2022</risdate><volume>28</volume><issue>2</issue><artnum>67</artnum><issn>1573-3149</issn><eissn>1573-3904</eissn><abstract>Antimicrobial peptides (AMPs) are present in many organisms ranging from insects to mammals. They have a selectivity as cationic and amphiphilic α-helical peptide molecules and might interact with tumor cell membranes. In this study, it was aimed to investigate the anticancer effects of cyclic dodecapeptide (CDP), which is an AMP on MCF-7 and MDA-MB 231 cells from breast cancer cell lines for the first time. Anticancer activity and mechanism of action of CDP were investigated via cancer cell viability assay, cell cytotoxic assay, acridine orange/ethidium bromide dual fluorescence dying assay and scanning electron microscope technique, solid phase heparan sulfate and chondroitin sulfate binding assay, and peptide binding assay. CDP decreases cell viability and induces the death of breast cancer cells by impairing the membrane integrity and causes necrotic cell death by forming pores in the membranes. CDP binds to the negatively charged glycosaminoglycans and shows more affinity against breast cancer cells than fibroblast cells. As a result, the anticancer activity of CDP presented for the first time against breast cancer cells and it has a therapeutic value due to its selective toxicity. Graphical Abstract</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10989-022-10369-2</doi><orcidid>https://orcid.org/0000-0002-7093-4744</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1573-3149
ispartof International journal of peptide research and therapeutics, 2022-03, Vol.28 (2), Article 67
issn 1573-3149
1573-3904
language eng
recordid cdi_proquest_journals_2627006932
source Springer Link
subjects Acridine orange
Animal Anatomy
Antimicrobial agents
Antimicrobial peptides
Antitumor activity
Apoptosis
Biochemistry
Biomedical and Life Sciences
Breast cancer
Cell death
Cell membranes
Cell viability
Chondroitin sulfate
Cytotoxicity
Ethidium bromide
Glycosaminoglycans
Heparan sulfate
Histology
Life Sciences
Molecular Medicine
Morphology
Peptides
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Polymer Sciences
Scanning electron microscopy
Tumor cell lines
Tumors
title Cyclic Dodecapeptide Induces Cell Death Through Membrane–Peptide Interactions in Breast Cancer Cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A11%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cyclic%20Dodecapeptide%20Induces%20Cell%20Death%20Through%20Membrane%E2%80%93Peptide%20Interactions%20in%20Breast%20Cancer%20Cells&rft.jtitle=International%20journal%20of%20peptide%20research%20and%20therapeutics&rft.au=Sancar,%20Serap&rft.date=2022-03-01&rft.volume=28&rft.issue=2&rft.artnum=67&rft.issn=1573-3149&rft.eissn=1573-3904&rft_id=info:doi/10.1007/s10989-022-10369-2&rft_dat=%3Cproquest_cross%3E2627006932%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c319t-ab89b3b900280318b1a753567aa81be735af781561d8da1b5809556353afbd413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2627006932&rft_id=info:pmid/&rfr_iscdi=true